Results 31 to 40 of about 2,830,257 (398)
Cerebral venous hemodynamic abnormalities in episodic and chronic migraine [PDF]
, 2016 Alterations of cerebral venous drainage have been demonstrated in chronic migraine (CM), suggesting that cerebral venous hemodynamic abnormalities (CVHAs) play a role in this condition.
Di Biase, A +7 more
core +1 more source
New players in the preventive treatment of migraine. [PDF]
, 2015 Migraine is a common, chronic disorder of the brain causing much disability, as well as personal, familial and societal impact. Several oral preventive agents are available in different countries for the prevention of migraine, but none have performed ...
Mitsikostas, Dimos D, Rapoport, Alan M
core +3 more sources
Efficacy and safety of eptinezumab in patients with chronic migraine
Neurology, 2020 Objective To evaluate the efficacy and safety of eptinezumab, a humanized anti–calcitonin gene-related peptide monoclonal antibody, in the preventive treatment of chronic migraine (CM). Methods The Prevention of Migraine via Intravenous ALD403 Safety and
R. Lipton +8 more
semanticscholar +1 more source
Characteristic oscillatory brain networks for predicting patients with chronic migraine
The Journal of Headache and Pain, 2023 To determine specific resting-state network patterns underlying alterations in chronic migraine, we employed oscillatory connectivity and machine learning techniques to distinguish patients with chronic migraine from healthy controls and patients with ...
Fu-Jung Hsiao +8 more
doaj +1 more source
Correlation of vestibular symptoms and headache in migraine patients: a clinical study of 424 cases
Di-san junyi daxue xuebao, 2021 Objective To evaluate the correlation between vestibular symptoms and headache in patients with migraine, and to explore the diagnostic value of vestibular symptoms in migraine.
LIU Juan +6 more
doaj +1 more source
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. [PDF]
, 2016 BACKGROUND: Refractory migraine is a challenging condition with great impact on health related quality of life. Intravenous (IV) ketamine has been previously used to treat various refractory pain conditions.
Ashina, Sait +3 more
core +3 more sources
Headache, 2021 To assess rates of and factors associated with traversing fundamental barriers to good medical outcomes and pharmacologic care in individuals with episodic migraine (EM) and chronic migraine (CM), including socioeconomic status and race.
D. Buse +6 more
semanticscholar +1 more source
Migraine and cluster headache show impaired neurosteroids patterns [PDF]
, 2019 Background: Perturbation of neuronal excitability contributes to migraine. Neurosteroids modulate the activity of γ-aminobutyric acid A and N-methyl-d-aspartate receptors, and might be involved in the pathogenesis of migraine.
Capi, M. +13 more
core +1 more source
A prospective real-world analysis of erenumab in refractory chronic migraine
The Journal of Headache and Pain, 2020 Background Clinical trials have shown the safety and clinical superiority of erenumab compared to placebo in chronic migraine (CM). The aim of this analysis is to evaluate the effectiveness and tolerability of erenumab in a real-world setting in patients
G. Lambru +4 more
semanticscholar +1 more source
Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
Toxins, 2015 Background: Chronic migraine is a common, highly disabling, underdiagnosed and undertreated entity of migraine. It affects 0.9%–2.2% of the general adult population.
Délia Szok +3 more
doaj +1 more source